Tags: Add Tags
  1. anonymous

    anonymous Guest

    story is unending ...solopath, sterilization, consent decree, warning letter, 483s, rto-plaunch with patient impact, recalls.....
     

  2. anonymous

    anonymous Guest

    not sure of details but some of this happens evrywhere
     
  3. anonymous

    anonymous Guest

    Like launch R2P Destination badly, with device getting stuck in human body, patient cut open to remove components, then passes away as a result of complications

    this happens everywhere?
     
  4. anonymous

    anonymous Guest

    it was aunique case - high risk patient from what I have heard
     
  5. anonymous

    anonymous Guest

    review HHE. check counter measures. this was not a case of high risk patient. possibly just one more bad lanuch
     
  6. anonymous

    anonymous Guest

    how long will these issues continue?
     
  7. anonymous

    anonymous Guest

    it is too entrenched both from incompetence view and malignant approach wise to go away easily. it is sad and unfortunate as a healthcare company
     
  8. anonymous

    anonymous Guest

    Seriously? This must be some of the dumbest list of complaints possible.

    To easily clear 250k+ every year with some of the best job security in medical sales I'll handle the "Solopath losses." ;-)
     
  9. anonymous

    anonymous Guest

    that is exactly the attitude the entire organization has so you will fit right in

    250K+ does compensate for patient deaths
     
  10. anonymous

    anonymous Guest

    Terumo paid 100 million for Harvest Technologies and has done absolutely nothing with it.

    This company is a complete and utter joke.
     
  11. anonymous

    anonymous Guest

    proud boys of doylestown, stand back and stand by
     
  12. anonymous

    anonymous Guest

    jr must have taken a cut like the deal with canada/pp
     
  13. anonymous

    anonymous Guest

    that was caught by our CFO - a big stink over the issue. chief of ethics screwed up big time
     
  14. anonymous

    anonymous Guest

    current cfo or previous one?
     
  15. anonymous

    anonymous Guest

    previous one. he was pressured into "legitimizing it"
     
  16. anonymous

    anonymous Guest

    it was escalated to samejema thru jt. hs had no choice with all the issues going on in tlac and microvention with the corruption and compliance violations. another ceo getting terminated for the same reasons would be a great "celebration" near 100 year year anniversary
     
  17. anonymous

    anonymous Guest

    Yeah, but they still manage to outgrow other companies in the endovascular space, so must be doing something right.
     
  18. anonymous

    anonymous Guest

    Its the exact same person posting 90% of the complaints about Terumo on Cafepharma. Each post has the same horrible grammar and punctuation. We get it, you couldn't hack it, good luck in the future.
     
  19. anonymous

    anonymous Guest

    very interesting
     
  20. anonymous

    anonymous Guest